DICE Therapeutics Inc. (DICE)
NASDAQ: DICE
· Real-Time Price · USD
47.55
0.03 (0.06%)
At close: Aug 08, 2023, 10:00 PM
DICE Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | 1.13M | 1.13M | 1.31M | 1.54M | 413K |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | 1.13M | 1.13M | 1.31M | 1.54M | 413K |
Operating Income | -118.69M | -100.94M | -88.22M | -77.98M | -72.94M | -58.38M | -47.6M | -38.46M | -28.3M | -21.13M |
Interest Income | 15.01M | 10.81M | 5.21M | 1.59M | 909K | 449K | 136K | 48K | 35K | 8K |
Pretax Income | -104.24M | -90.94M | -83.89M | -76.86M | -73.64M | -59.48M | -48.96M | -39.89M | -28.57M | -21.21M |
Net Income | -97.08M | -83.98M | -82.86M | -76.44M | -73.84M | -59.48M | -48.96M | -39.89M | -28.57M | -21.21M |
Selling & General & Admin | 32.01M | 28.13M | 25.66M | 23.3M | 21.3M | 16.2M | 12.22M | 9.42M | 6.72M | 4.41M |
Research & Development | 86.68M | 72.81M | 62.56M | 54.68M | 51.64M | 43.3M | 36.51M | 30.35M | 23.12M | 17.14M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 118.69M | 100.94M | 88.22M | 77.98M | 72.94M | 59.5M | 48.73M | 39.77M | 29.84M | 21.54M |
Interest Expense | 554K | 619K | 679K | 268K | 245K | 232K | 174K | 116K | 59K | 7K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 118.69M | 100.94M | 88.22M | 77.98M | 72.94M | 59.5M | 48.73M | 39.77M | 29.84M | 21.54M |
Income Tax Expense | -7.16M | -6.96M | -1.03M | -500K | 179K | 31K | 33K | 116K | 59K | 7K |
Shares Outstanding (Basic) | 47.31M | 47.19M | 45.43M | 37.48M | 37.36M | 37.26M | 37.16M | 7.55M | 34.32M | 23.23M |
Shares Outstanding (Diluted) | 47.31M | 47.19M | 45.43M | 37.48M | 37.36M | 37.26M | 37.16M | 7.55M | 34.32M | 23.23M |
EPS (Basic) | -2.19 | -2.03 | -2.11 | -2.05 | -3.82 | -3.45 | -3.3 | -3.17 | -1.13 | -0.92 |
EPS (Diluted) | -2.19 | -2.03 | -2.11 | -2.05 | -3.82 | -3.45 | -3.3 | -3.17 | -1.13 | -0.92 |
EBITDA | -102.4M | -88.83M | -81.19M | -74.58M | -70.67M | -57.08M | -46.96M | -37.73M | -27.57M | -20.6M |
EBIT | -74.8M | -96.25M | -83.21M | -76.59M | -73.4M | -59.23M | -48.77M | -39.75M | -28.49M | -21.21M |
Depreciation & Amortization | 11.61M | 12.11M | 6.7M | 3.16M | 2.01M | 1M | 661K | 677K | 700K | 521K |